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Laparo-Endoscopic Single-Site surgery (LESS) for kidney diseases is quickly evolving and has a tendency to expand the urological
armory of surgical techniques. However, we should not be overwhelmed by the surgical skills only and weight it against the basic
clinical and oncological principles when compared to standard laparoscopy. The initial goal is to deﬁne the ideal candidates and
idealcentersforLESSinthefuture.Modiﬁcationofbasicinstrumentsinlaparoscopypresumablycannotresultinbetterfunctional
andoncologicaloutcomes,especiallywhentheoptimalworkingspaceislimitedwiththesamearmmovements.Singleportsurgery
is considered minimally invasive laparoscopy; on the other hand, when using additional ports, it is no more single port, but hybrid
traditional laparoscopy. Whether LESS is a superior or equally technique compared to traditional laparoscopy has to be proven by
future prospective randomized trials.
1.Introduction
Laparo-endoscopic single-site surgery (LESS) as a new alter-
native to conventional laparoscopy has gained popularity.
Todaylaparoscopyhaschangedkidneysurgeryatall.Laparo-
scopic radical nephrectomy is gold standard when opting for
radicalnephrectomyinT1b-T2renalcellcancer[EAU+AUA
guidelines], but furthermore, laparoscopy is preferred for
pyeloplasty and is comparable in nephron-sparing surgery
for T1a renal tumors and in nephroureterectomy [1], some
ofthemhavealsobeen described inthepediatric poplulation
[2].
Various terms have been used for LESS up to date, but
the ﬁnal deﬁnition has been established in July 2008 by
the Laparo-Endoscopic Single-Site Surgery Consortium for
Assessment and Research (LESSCAR) as laparo-endoscopic
single-site surgery (LESS) [3] .T h e r ea r es e v e r a li m p o r t a n t
questions that should be answered until LESS will be equiv-
alent with standard laparoscopy (SL). Is there any overall
beneﬁt for the patients in terms of risk of perioperative,
postoperative morbidity, and oncological safety?
Should we limit surgeons comfort and conﬁdence?
Which population of patients will actually beneﬁt and what
are the optimal indications? The aim of our minireview
is to critically summarize pros and cons of LESS in renal
surgery.
2. PotentialAdvantagesand Disadvantages
Although LESS is a rapidly evolving surgical minimally
invasivetechnique,publishedreportsarelimited bynumbers
of patients and centers [1–9]. Meanwhile, it is very doubtful
if LESS is going to further improve SL. Unproven potential
advantages of single port surgery are only less scar, less
discomfort, reduced postoperative pain, and thus less use
of analgetic medication, followed with faster recovery and
shorter hospital stay when compared to the traditional open
and SL. LESS is feasible, with comparable perioperative
and postoperative outcomes with limited follow up when
compared to SL [1–11]. Beacause only the surgical technique
itself has been modiﬁed, it is very uncertain that the
oncological or clinical outcomes will be better than in SL.
LESS creates a challenge for surgeons and increases their
skillsandambidexterity.Fromourowninitialexperience,we
think LESS is ideal for renal, adrenal cysts, cryoablation of
small renal masses; however, we prefer the lower abdomen2 Diagnostic and Therapeutic Endoscopy
instead of the umbilicus for single port placement. Postop-
erative pain does not seem to be reduced compared to the
SL surgical procedure (our unpublished data). We think that
the overall beneﬁt of LESS is lacking today. Even in high-
volume laparoscopic centers like ours, the key issue will be
right patient selection.
The incision length varies usually from 1 to 6cm [5, 6].
In SL for renal tumors, we use 2(1) 12mm ports, 1(2) 5mm
port, and eventually another 5 or 12mm port (overall length
34mm). Of course an additional incision has to be made
for organ extraction, but this is also true for LESS, unless
natural oriﬁcions will be used or morcelleration like in the
beginning of SL is used. The only diﬀerence is the range of
few centimeters. Do we really have to measure the clinical
equivalence of surgical procedure by cosmetics, or do we
actually measure and compete ourselves as surgeons? The
need is to critically evaluate this novel approach especially
in patients with neoplasms.
The maneuverability of instruments is more diﬃcult in
the single port platform, which might be overcome with
the learning curve. Easier clashing of working instruments
results in limited operating ﬁelds. Therefore, using an
additional port is sometimes necessary [6]; others tend to
insert percutaneously 3mm small instruments [5], without
addinganadditionalportandthustryingtofulﬁllthecriteria
of single port laparoscopy. Introduction of these advanced
technologies and instruments (roticulating forces, ﬂexible
laparoscopic scissors, graspers) tends to overcome these
limitations[3],whichraisesthequestion:isthismodiﬁcation
of basic principle necessary?
Certainly those who will not perform many cases or at
least on a regular basis, do not get better results.
3. Ideal Indications
LESS is a challenging operation for an experienced laparo-
scopic surgeon [7]. It seems that in the future LESS will be
equally eﬃcocious and feasible to SL in high-volume centers.
However, the main and probably the only advantage stays
the single scar with potential increase in overall costs when
compared to SL.
Who will mainly beneﬁt from LESS renal surgery: (1)
patients who are most concerned of cosmesis, (2) nonextir-
pative surgeries such as renal, adrenal cyst marsupialization,
pyeloplasty, renal tumor ablative techniques, or simple
nephrectomy for small nonfunctioning kidney, (3) radical
nephrectomy with morcelation where the lengthening of an
incision is not necessary, which is on the other hand an
oncological compromise and clearly will reduce postopera-
tive oncological assessments.
From our own experience, renal, adrenal cyst marsupi-
alization and cryoblation of small renal mass were the ideal
indications to start with comparable overall outcomes when
compared to SL. Radical nephrectomy was feasible for an
experienced laparoscopist equally in terms of perioperative
and postoperative parameters as with SL. We have experi-
enced two conversions due to adhesions in patients with
previous abdominal surgery (unpublished data) to SL. Goel
and Kaouk recommend cryoablation as an ideal procedure
to start with single port surgery from their experience as well
[12].
Patients with conventional contraindications to SL, pre-
vious ipsilateral renal surgery, or the presence of a solitary
kidney should not be the candidates for LESS [8], at least
initiallyoruntilthesurgeonfeelsthesameconﬁdenceaswith
SL.
Partial nephrectomy remains to be very challenging even
forlaparoscopistsinhigh-volumecenters,withanexperience
over 950 SL partial nephrectomy cases. The major problem
was the tissue retraction and therefore the ideal candidates
would be nonobese, medium height with anterior exophytic
lower pole tumor less than 4cm with no previous abdominal
surgery, with the possibility of extirpation without hilar
clamping [7, 13].
In general SL has a higher ischemia time than open
nephron-sparing surgery and thus has not reached the
full competitive potential to open nephron-sparing surgery.
That is why, LESS will certainly not reduce ischemia times,
which is clearly a safety issue for the further kidney-function
and the health of the patient.
Maybe LESS is a crossing bridge to the integration of
LESS and robotics? What has been proved by Desai et
al. in robot/assisted-LESS pyeloplasty, where other working
instruments were inserted through separate fascial puncture,
but through the umbilical incision [6]? It looks like a logical
next step, because freedom of movement in robotic surgery
eliminates basic limitations of this novel approach itself.
We do have to be critical to ourselves, because to date we
can review a small volume of outcomes. As far as all these
reports are initial, we should not expect the better outcomes,
but comparable, what seems to be proven [1].
Last but not least, the overall rate of complications of
laparoscopic procedures in urology is quite low (around
0.2%) [11]. Will be the “one scar LESS surgery” related
to lower incidence of complications? Comparison of SL
versus hand assisted laparoscopic renal surgery so far did
not prove the fact that a smaller incision has a better
outcome [9]. To date limited data on postoperative, port
related morbidity, and cosmetics are still to be proven in
comparative prospective trials. Surgeons are doctors at ﬁrst
and that is why novel techniques should not result in a race
and competition in surgical minimalism.
4. FutureImprovements of Less Technique
Further technical improvements to minimize the invasive-
ness and upgrade LESS surgery are in progress. Magnetic
anchoring and guidance system (MAGS) technology (by
developing of magnetically controlled and anchored intra-
corporeal surgical instruments) seems to be a promising
technique to facilitate and advance LESS surgery [14]. A
generated magnetic ﬁeld, as we can obtain in magnetic
resonanceimaging,isregardedastheleastprocedurethatcan
bemedicallyapplied.Oneofthelimitationsofthisprocedure
is that the extracorporeal electromagnetic control system is
too large, that is why the size needs to be miniaturized.
Introduction of da Vinci robotic platform in combina-
tion with single port surgery is encouraging and appearsDiagnostic and Therapeutic Endoscopy 3
to overcome some limitations of single port laparoscopic
surgery itself. It is beneﬁcial especially during intracorporeal
suturing by improving ergonomics.
The second generation laparoscopic instruments and the
upgraded generation of intuitive robotic systems are a must
to achieve the potential goals of LESS technique.
The smaller is the incision the greater need is for
smaller instruments and robots. What does it mean for the
future? Development of minirobots anchored intraabdom-
inally through the speciﬁc platforms. We are already on
the beginning of the minirobotic revolution and translation
from mini invasive surgery to pure intracavitary surgery. The
technical potential of “in vivo robots” has to be investigated,
well deﬁned, and established in the clinical ﬁeld to eliminate
the diﬃculties in LESS surgeries [15].
5. Conclusions
LESS has a potential in reduction of postoperative pain and
cosmetics, but should these beneﬁts justify the use of single
port surgery over traditional laparoscopy? One can presume
that the modiﬁcation of instruments of laparoscopic tech-
nique in general will not result in better clinical or even more
in oncological outcomes. Certainly, we can not compete the
fact that LESS is a challenging technique and increases the
skills and ambidexterity of the surgeons. However, we should
take LESS into account and weight against basic clinical
and oncological principles. At the moment, the suﬃcient
“yes” for LESS as a supreme technique over the traditional
laparoscopy has to proven by future prospective randomized
trials. We think that LESS will play a role, but a minor role in
laparoscopic renal surgery.
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